Research location
Sátoraljaújhely
Hungary
Advertisement
Research activity in Sátoraljaújhely
HungaryCureCurrent currently publishes aggregate city-level research activity for this location: 28 trials and 28 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sátoraljaújhely
28 linked trials · page 1 of 1A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy AloneNCT02531035 · 2015-09-01 · 1 site observation
COMPLETED
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot UlcersNCT02447172 · 2015-06-01 · 1 site observation
COMPLETED
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin GlargineNCT02294474 · 2015-01-01 · 1 site observation
COMPLETED
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes MellitusNCT02229383 · 2014-09-06 · 1 site observation
COMPLETED
Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DMNCT02058147 · 2014-02-01 · 1 site observation
COMPLETED
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation
COMPLETED
Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 DiabetesNCT01834274 · 2013-06-01 · 1 site observation
TERMINATED
Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsNCT01768559 · 2013-01-01 · 1 site observation
COMPLETED
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)NCT01621178 · 2012-07-01 · 1 site observation
COMPLETED
Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in HungaryNCT01534936 · 2012-02-01 · 1 site observation
COMPLETED
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic NephropathyNCT01447147 · 2011-10-01 · 1 site observation
COMPLETED
An Open Label Study for Participants With Rheumatoid ArthritisNCT01215942 · 2011-06-01 · 1 site observation
TERMINATED
A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPDNCT01313637 · 2011-03-01 · 1 site observation
COMPLETED
A Rheumatoid Arthritis Study in ParticipantsNCT01202760 · 2011-01-01 · 1 site observation
COMPLETED
A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateNCT01198002 · 2010-12-01 · 1 site observation
TERMINATED
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South StudyNCT01217463 · 2010-11-01 · 1 site observation
COMPLETED
Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled AsthmaNCT01225315 · 2010-11-01 · 1 site observation
COMPLETED
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationNCT01195662 · 2010-10-01 · 1 site observation
COMPLETED
Seroquel XR in the Long Term Treatment of SchizophreniaNCT01202617 · 2010-09-01 · 1 site observation
COMPLETED
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerNCT01137474 · 2010-07-01 · 1 site observation
COMPLETED
Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)NCT01146652 · 2010-06-21 · 1 site observation
COMPLETED
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes MellitusNCT01144338 · 2010-06-18 · 1 site observation
COMPLETED
A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal ImpairmentNCT01043029 · 2010-05-01 · 1 site observation
COMPLETED
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis PatientsNCT01061736 · 2010-03-01 · 1 site observation
COMPLETED
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes MellitusNCT01028963 · 2010-01-01 · 1 site observation
COMPLETED
Seroquel XR in Schizophrenia Relapse PreventionNCT00990626 · 2009-10-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic PatientsNCT00929539 · 2009-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.